LINK WILLIAM J PHD
SEC Form 4 insider trading activity
LINK WILLIAM J PHD has filed 8 SEC Form 4 filings (15 transaction rows) across 3 companies, including RXST, TARS, LNSR, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jun 18, 2026.
On the most recent filing, LINK WILLIAM J PHD is listed as Director at Tarsus Pharmaceuticals, Inc. Inside the rolling window, LINK WILLIAM J PHD reported no open-market purchases and 3 open-market sales totaling $3.5M in TARS. The largest disclosed transaction in the window is a sale of 22,946 TARS shares on Dec 15, 2025, worth $1.9M.
Companies traded
Other insiders at RXST
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$3.5M
reported sales (SEC code S)
Companies
3
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 8, 2025 | TARS | Sale | $1.5M |
Frequently asked questions
How many SEC Form 4 filings has LINK WILLIAM J PHD made?
LINK WILLIAM J PHD has filed 8 SEC Form 4 filings (15 transaction rows) across 3 companies, including RXST, TARS, LNSR since 2025.
Which companies does LINK WILLIAM J PHD trade?
LINK WILLIAM J PHD has filed SEC Form 4 disclosures for 3 companies, including RXST, TARS, LNSR.
When was LINK WILLIAM J PHD's most recent SEC Form 4 filing?
LINK WILLIAM J PHD's most recent SEC Form 4 filing on Tracefour is dated Jun 18, 2026.
What is LINK WILLIAM J PHD's total buy and sell value in the current window?
Inside the rolling retention window, LINK WILLIAM J PHD bought $0 and sold $3.5M based on SEC Form 4 filings.
What was LINK WILLIAM J PHD's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 22,946 TARS shares on 2025-12-15, worth $1.9M, per SEC Form 4 filings.